133 related articles for article (PubMed ID: 6392599)
1. Antimicrobial susceptibility of Serratia marcescens isolated from clinical materials.
Igari J; Oguri T; Kosakai N
Jpn J Antibiot; 1984 Sep; 37(9):1625-30. PubMed ID: 6392599
[TBL] [Abstract][Full Text] [Related]
2. [O-serotypes, biochemical properties and antimicrobial susceptibilities of Serratia marcescens isolated from clinical specimens (2nd report)].
Marumo K; Takeuchi T; Aoki Y
Rinsho Byori; 1990 Sep; 38(9):1077-82. PubMed ID: 1700174
[TBL] [Abstract][Full Text] [Related]
3. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
[TBL] [Abstract][Full Text] [Related]
4. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Fujime M; Fujita K; Shigeta S; Watanabe J; Igari J; Ogiwara M; Ishibashi K; Oguri T; Yoshida H; Imafuku Y; Yamaguchi K; Matsumoto T; Kashitani F; Murai M; Ooe H; Nishikawa M; Watanabe K; Kobayashi Y; Uchida H; Oka T; Mochida C
Jpn J Antibiot; 1999 Feb; 52(2):93-129. PubMed ID: 10221177
[TBL] [Abstract][Full Text] [Related]
5. [O-serotypes, biotypes and antimicrobial susceptibilities of Serratia marcescens isolates from clinical specimens: 4th report].
Marumo K; Nakamura Y; Fukuda S
Rinsho Byori; 1995 Nov; 43(11):1140-6. PubMed ID: 8551678
[TBL] [Abstract][Full Text] [Related]
6. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). I. Susceptibility distribution].
Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
Jpn J Antibiot; 1995 Sep; 48(9):1131-60. PubMed ID: 7474333
[TBL] [Abstract][Full Text] [Related]
7. [Susceptibility of recent clinical isolates of Pseudomonas aeruginosa and Serratia marcescens to cefotaxime, ceftizoxime, cefmenoxime, latamoxef and cefsulodin in comparison with other beta-lactam antibiotics and aminoglycosides].
Kawakami Y; Okimura Y; Horiuchi N; Kanai M
Jpn J Antibiot; 1982 Sep; 35(9):2314-7. PubMed ID: 6292543
[No Abstract] [Full Text] [Related]
8. Comparative susceptibilities of clinical isolates of Serratia marcescens to newer cephalosporins, alone and in combination with various aminoglycosides.
Markowitz SM; Sibilla DJ
Antimicrob Agents Chemother; 1980 Nov; 18(5):651-5. PubMed ID: 7004344
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibilities and bacteriological characteristics of bovine Pseudomonas aeruginosa and Serratia marcescens isolates from mastitis.
Ohnishi M; Sawada T; Hirose K; Sato R; Hayashimoto M; Hata E; Yonezawa C; Kato H
Vet Microbiol; 2011 Dec; 154(1-2):202-7. PubMed ID: 21783330
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility of clinical isolates of Serratia marcescens.
Alvarez JS; Regueiro B; Garrido MJ
Antimicrob Agents Chemother; 1979 Oct; 16(4):523-4. PubMed ID: 391150
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic susceptibility of Serratia marcescens and Serratia liquefaciens.
Traub WH
Chemotherapy; 2000; 46(5):315-21. PubMed ID: 10965096
[TBL] [Abstract][Full Text] [Related]
12. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1986). III. Secular changes in susceptibility].
Kosaki N; Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Yoshida H; Ogata M; Tazaki H
Jpn J Antibiot; 1989 Oct; 42(10):2189-312. PubMed ID: 2607604
[TBL] [Abstract][Full Text] [Related]
13. [Epidemiological evaluation of Serratia marcescens isolates in one Japanese hospital during the two years from April 1997 to March 1999].
Marumo K; Nakamura Y; Togashi M
Rinsho Byori; 2000 Oct; 48(10):960-5. PubMed ID: 11215111
[TBL] [Abstract][Full Text] [Related]
14. Drug resistance, R plasmids and pigmentation of Serratia marcescens isolated in Taiwan.
Ding MJ; Sung SJ
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Feb; 20(1):69-79. PubMed ID: 3297535
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic resistance patterns of clinical isolates of Serratia marcescens.
Cooksey RC; Bannister ER; Farrar WE
Antimicrob Agents Chemother; 1975 Apr; 7(4):396-9. PubMed ID: 1096799
[TBL] [Abstract][Full Text] [Related]
16. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1992). I. Susceptibility distribution].
Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
Jpn J Antibiot; 1995 Nov; 48(11):1627-57. PubMed ID: 8558754
[TBL] [Abstract][Full Text] [Related]
17. Serratia marcescens: biochemical, serological, and epidemiological characteristics and antibiotic susceptibility of strains isolated at Boston City Hospital.
Wilfert JN; Barrett FF; Ewing WH; Finland M; Kass EH
Appl Microbiol; 1970 Feb; 19(2):345-52. PubMed ID: 4314379
[TBL] [Abstract][Full Text] [Related]
18. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1991). I. Susceptibility distribution].
Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
Jpn J Antibiot; 1995 Oct; 48(10):1394-421. PubMed ID: 8544337
[TBL] [Abstract][Full Text] [Related]
19. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1987). III. Secular changes in susceptibility].
Kosakai N; Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Yoshida H; Ogata M; Tazaki H
Jpn J Antibiot; 1990 Jun; 43(6):968-1136. PubMed ID: 2122041
[TBL] [Abstract][Full Text] [Related]
20. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1993). I. Susceptibility distribution].
Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H
Jpn J Antibiot; 1995 Nov; 48(11):1757-87. PubMed ID: 8558757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
